Abstract
A 65 year old male, recently diagnosed as a case of pulmonary tuberculosis, on antitubercular treatment for the past 2 months, presented to emergency department with history of coughing out blood. For the past 2 weeks, he has a history of sputum streaking of blood, but today morning, he expectorated about a cup of bright red blood. While giving history of his symptoms, he expectorated large amount of blood, about 300 mL.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Abal AT, Nair PC, Cherian J. Haemoptysis: aetiology, evaluation and outcome—a prospective study in a third world country. Respir Med. 2001;95:548–52. This article gives a comprehensive review of the assessment and management of hemoptysis.
De Gracia J, de la Rosa D, Catalán E, Alvarez A, Bravo C, Morell F. Use of endoscopic fibrinogen-thrombin in the treatment of severe hemoptysis. Respir Med. 2003;97:790–5. The topical treatment with fibrinogen-thrombin could be considered in the initial endoscopic evaluation of the patients with severe hemoptysis while awaiting BAE or surgery, or as alternative treatment to arterial embolization when the latter is not available, has proved ineffective.
Dupree HJ, Lewejohann JC, Gleiss J, Muhl E, Bruch HP. Fiberoptic bronchoscopy of intubated patients with life-threatening hemoptysis. World J Surg. 2001;25:104–7. Widespread use of flexible bronchoscopy makes this procedure immediately applicable in critical situations. Intubated and mechanically ventilated patients with life-threatening hemoptysis especially benefit from this rapidly feasible procedure.
Jean-Baptiste E. Clinical assessment and management of massive hemoptysis. Crit Care Med. 2000;28:1642–7. This article gives comprehensive review of assessment and management of hemoptysis.
Larici AR, et al. Diagnosis and management of hemoptysis. Diagn Interv Radiol. 2014;20(4):299–309.
MacDonald JA, Fraser JF, Foot CL, Tran K. Successful use of recombinant factor VII in massive hemoptysis due to community-acquired pneumonia. Chest. 2006;130:577–9. Recombinant factor VII may be a useful temporizing measure in the unstable patient with pulmonary hemorrhage without coagulopathic bleeding when conventional treatment is not immediately available.
Ong TH, Eng P. Massive hemoptysis requiring intensive care. Intensive Care Med. 2003;29:317–20. Embolization is a suitable first-line treatment for massive hemoptysis not responding to conservative treatment, reserving emergency surgery for cases in which the above measures are insufficient to control bleeding.
Razazi K, Parrot A, Khalil A, et al. Severe haemoptysis in patients with nonsmall cell lung carcinoma. Eur Respir J. 2015;45:756.
Yoon W, Kim JK, Kim YH, Chung TW, Kang HK. Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review. Radiographics. 2002;22:1395–409. BAE is a safe and effective nonsurgical treatment for the patients with massive hemoptysis. However, nonbronchial systemic arteries can be a significant source of massive hemoptysis and a cause of recurrence after successful BAE.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Bansal, A., Shekhar, R. (2020). Massive Hemoptysis. In: Chawla, R., Todi, S. (eds) ICU Protocols. Springer, Singapore. https://doi.org/10.1007/978-981-15-0898-1_10
Download citation
DOI: https://doi.org/10.1007/978-981-15-0898-1_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-0897-4
Online ISBN: 978-981-15-0898-1
eBook Packages: MedicineMedicine (R0)